Wednesday, June 6, 2007

 Merck's

 Merck's Mess Forbes - Find Articles

 FIND  IN free and premium articles free articles only premium articles only this publication Arts Autos Business Health Home & Garden News Reference Sports TechnologyAdvancedSearch  (Related) 

saveprint  (Related) share  (Related) link

 Content provided

 in partnership with

 It yanked Vioxx three years after the first studies raised safety alarms. That delay could hurt patients and shareholders alike.

  On Sept 3. Newton Acker, 71, died of a stroke while on a bicycling vacation with his wife in southern France. His three grown children were stunned. Apart from his arthritis, Acker was exceptionally healthy.He had low cholesterol and low blood pressure and bicycled 5,000 miles a year. His parents had lived to age 90.

 Four weeks later Merck &Co. pulled Vioxx from the market after a study showed it doubled the risk of heart attacks and stroke. "That's the answer,"Acker's son, Kenneth, an F-16 training pilot in Arizona, immediately thought. His dad had been taking Vioxx for 14 months before his death. Kenneth blames Merck for failing to act sooner and plans to sue. "We don't need the money. We just want my father back," he says. ...

Read the full article  (Related)   with a Free Trial at MyWire.


















No comments: